Genpharmasec Limited (BOM:531592)
India flag India · Delayed Price · Currency is INR
1.080
0.00 (0.00%)
At close: Nov 17, 2026

Genpharmasec Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
2,3061,399337.22304.06255.16273.21
Revenue Growth
243.33%314.98%10.91%19.16%-6.61%28.22%
Gross Profit
171.26113.5829.761.7321.187.55
Operating Income
8.07-7.99-1.830.042.48-5.36
Net Income
25.6116.0415.86-1.6911.25-2.09
Earnings Per Share
0.020.030.03-0.010.04-0.01
EPS Growth
1047.69%1.12%----

Revenue by Segment

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Pharmaceuticals
2,1701,309325.59304.06252.83266.11
Manufacturing & Processing
133.8580.62----
Laboratory Testing
-10.0511.63---
Total
2,3061,399337.22304.06255.16273.21

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
54.25100.7452.71217.7636.5659.41
Total Debt
238.67349.4752.8538.8930.82-
Net Cash (Debt)
-184.42-248.73-0.13178.875.7459.41
Net Cash Growth
---3018.39%-90.34%-58.52%
Net Cash Per Share
-0.16-0.45-0.000.580.020.21

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-182.01-175.5229.51-29.46-30.6-23.44
Capital Expenditures
-0.63-5.21-57.05-0.18-0.16-0.81
Free Cash Flow
-182.64-180.73-27.54-29.64-30.76-24.25
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
7.43%8.12%8.81%20.30%8.30%2.77%
Operating Margin
0.35%-0.57%-0.54%0.01%0.97%-1.96%
Pretax Margin
1.02%0.69%6.56%0.82%1.10%-1.62%
Profit Margin
1.11%1.15%4.70%-0.56%4.41%-0.77%
FCF Margin
-7.92%-12.91%-8.17%-9.75%-12.05%-8.88%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
48.2626.9363.60-76.55-
PS Ratio
0.260.312.994.063.385.57